December 7, 2023
In a paper, published in Science Translational Medicine, we have showed that JUVIAGEL could be effective against recurrent yeast infections. More in our Press Release.
UPCOMING EVENTS
CPHI Milan, October 8-10, 2024, Milan, Italy
We are excited to exhibit this year’s CPHI, one of the world’s largest pharma event, taking place on October 8-10, 2024 in Milan, Italy.
You can meet us and discover our innovative product portfolio at
our stand 6SU32 in Hall 6 zone Excipients
BIO International Convention
June 16-19, 2025 Boston, USA
We are excited to be visiting BIO 2025, the world’s largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with more than 18,500 industry leaders from across the globe.
RECENT NEWS
-
-
-
July 17, 2023
Fempharma has been successfully audited for ISO 13485:2016 Manufacturing and Trade of Medical Devices by Tequa-Zert, a TÜV Hessen partner. -
June 25th, 2023
We have presented our latest study “A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle... Read More -
June 22, 2023
Our latest study about the efficacy of INCOXIL has been published at the BMC Women’s Health titled “A randomized controlled pilot trial to assess the... Read More -
May 21st, 2023
We have presented our latest study “A randomized controlled trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training... Read More -
May 19th, 2023
New clinical trial for Juvia has started. Vaginitis is one of the most common gynecological problems in women. Candida albicans is responsible for more than... Read More -
May 4th, 2023
Fempharma’s proprietary vaginal moisturizer gel JUVIA has gotten into the shelves at Rossmann Hungary.
